A review examines how diabetes causes heart failure through metabolic mechanisms and how heart failure induces new-onset diabetes through insulin signaling disruption.
Bidirectional damageDiabetes drives heart failure through metabolic injury; heart failure triggers new diabetes through insulin disruption
What the researchers found
Diabetes and heart failure have a bidirectional pathophysiological relationship where each condition actively promotes and worsens the other.
Why it matters
With both conditions rising globally, understanding their mutual reinforcement is critical for developing effective treatment strategies that address both simultaneously.
How the study worked
Narrative review of the epidemiological, mechanistic, and clinical interplay between diabetes mellitus and heart failure.
What this study cannot tell us
Narrative review — comprehensive but selective; the complexity of bidirectional pathophysiology makes specific therapeutic recommendations difficult.
How to read the evidence
Narrative review — synthesizes mechanistic and clinical evidence for the bidirectional diabetes-HF relationship.
When this study was published
Published 2026 in Diabetology International.
The bigger picture
The diabetes-heart failure nexus exemplifies why treating metabolic disease requires integrated approaches rather than siloed specialty care.
Questions still open
- Should all heart failure patients be screened for diabetes and vice versa?
- Can early metabolic intervention prevent the diabetes-heart failure cycle?
Common questions
Can heart failure cause diabetes?
What treatments help both diabetes and heart failure?
Read the original research
Concurrent diabetes and heart failure: revisiting epidemiological and clinicopathological interplay.
Diabetology international, 17(1), 12
Citation
Balagopalan, Jayagopal Pathiyil; Bansal, Sandeep; Bhattacharyya, Arpandev; Zargar, Abdul Hamid; Dani, Sameer; Taraphder, Abhijit; Almeida, Alan; Deka, Nilakshi; Jain, Sanjay; Swami, Onkar C. (2026). Concurrent diabetes and heart failure: revisiting epidemiological and clinicopathological interplay.. Diabetology international, 17(1), 12. https://doi.org/10.1007/s13340-025-00855-5